Results 121 to 130 of about 61,216 (299)

A comparative evaluation of the antimicrobial efficacy of triple antibiotic paste, clindamycin, and linezolid as an intracanal medicament against Enterococcus faecalis: An in vitro study

Endodontology
Aim: The aim of the present study was to evaluate and compare the antimicrobial efficacy of three medicaments, triple antibiotic paste (TAP), clindamycin (CLID), and linezolid (LZ) against Enterococcus faecalis, using spectrophotometry.
Priya Chauhan, Bhavya Akotiya, Anjali Surana, Suparna Ganguly Saha, Rolly S. Agarwal, Mainak Kanti Saha   +5 more
doaj   +1 more source

Institutional Trends in Penicillin Allergy: A New Era of Active Penicillin Allergy Delabeling

Clinical &Experimental Allergy, EarlyView.
Anna Brameli, Allison B. McCoy, Elizabeth McNeer, Leena Choi, Joanna L. Stollings, Grace Koo, Allison E. Norton, Milner Staub, George E. Nelson, James W. Antoon, Sophie E. Katz, Ritu Banerjee, Adam Wright, Elizabeth J. Phillips, Cosby A. Stone Jr.   +14 more
wiley   +1 more source

Estradiol-Induced Modulation of Clindamycin Susceptibility in Mono- and Dual-Species Biofilms of Lactobacillus gasseri and Cutibacterium acnes: An In Vitro Model Study

Microorganisms
This pilot study investigated the effects of estradiol and clindamycin on mono- and dual-species biofilms of selected reference and clinical isolates of Lactobacillus gasseri and Cutibacterium acnes, including one vaginal isolate of C. acnes.
Varvara P. Pavlova, Artem G. Chebotarevskii, Ecaterina V. Diuvenji, Nadezhda A. Loginova, Anna M. Mosolova, Aleksandra S. Novikova, Sergey V. Martyanov, Marina V. Sukhacheva, Alexander I. Netrusov, Andrei V. Gannesen   +9 more
doaj   +1 more source

Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) syndrome associated with cefotaxime and clindamycin use in a 6 year-old boy: a case report

The Pan African Medical Journal, 2017
Drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome is a rare and potentially life-threatening idiosyncratic drug reaction. It presents with extensive rash, fever, lymphadenopathy, hematologic abnormalities (eosinophilia and/or ...
Burcu Karakayalı, Ahmet Sami Yazar, Deniz Çakir, Aysen Cetemen, Mandana Kariminikoo, Burak Deliloglu, Sirin Guven, Ismail Islek   +7 more
doaj   +1 more source

Methicillin‐resistant Staphylococcus aureus bloodstream infections in the Northern Territory of Australia 2017–2022

Internal Medicine Journal, EarlyView.
ABSTRACT Background Methicillin‐resistant Staphylococcus aureus (MRSA) bloodstream infections (BSIs) cause significant morbidity and mortality. In Australia's Northern Territory (NT), MRSA BSI prevalence is disproportionately high. Vancomycin remains standard therapy despite toxicity and complex monitoring requirements.
Sara Davison, Aliya Bryce, Duncan Campbell, Robert Baird, Thomas Ewin, Shahid Ullah, Sonja Janson, Danny Tsai   +7 more
wiley   +1 more source

Modern approach to treatment of a recurrent bacterial vaginosis at women of the reproductive period [PDF]

Гинекология, 2018
Bacterial vaginosis is closely associated with increase in frequency of inflammatory diseases of woman's pelvis organs, infertility, spontaneous abortions, preterm labor, contaminating fetus, postnatal inflammatory complications and cervical neoplasia ...
T Yu Pestrikova, E A Yurasova, A V Kotelnikova, N V Strelnikova, Yu V Voronova, A V Chirkov   +5 more
doaj  

Delphi consensus: First‐line use of biologics and small molecules in hidradenitis suppurativa

Journal of the European Academy of Dermatology and Venereology, EarlyView.
This Delphi Consensus study identified upgrade criteria for the use of biologics and small molecules as first‐line therapy in hidradenitis suppurativa (HS). European HS experts evaluated 16 clinical scenarios, voting on eligibility for therapy escalation.
Georgios Nikolakis, Erkan Alpsoy, Florian Anzengruber, Matthias Augustin, Falk G. Bechara, Pierre‐André Becherel, Farida Benhadou, Vincenzo Bettoli, Joana Cabete, Raffaele Dante Caposiena Caro, Antonella Di Cesare, Giovanni Damiani, Valentina Dini, Evangelos J. Giamarellos‐Bourboulis, Krisztián Gáspár, Katalin Glasenhardt, Philippe Guillem, Ariela Hafner, Barbara Horvath, John R. Ingram, Vaiva Jarienè, Gregor B. E. Jemec, Alexander Katoulis, Natalia Kirsten, Georgios Kokolakis, Piotr K. Krajewski, Aikaterini I. Liakou, Flavia Manzo Margiotta, Angelo V. Marzano, Antonio Martorell, Lukasz Matusiak, Dillon Mintoff, Alejandro Molina Leyva, Andreas Pinter, Anna Pirogova, Maurizio Podda, Francesca Prignano, Jorge Romani, Marco Romanelli, Elia Rosi, Samed Sahin, Ditte M. L. Saunte, Sylke Schneider‐Burrus, Mariano Suppa, Jacek Szepietowski, Andrea Szegedi, Simon Francis Thomsen, Thrasyvoulos Tzellos, Anastasia Trigoni, Hessel H. Van Der Zee, Kelsey Van Straalen, Skaidra Valiukevičiene, Eva Vilarrasa, Esther von Stebut, Christos C. Zouboulis   +54 more
wiley   +1 more source

Ability of Linezolid to Combat Staphylococcus aureus and Pseudomonas aeruginosa Isolated from Polymicrobial Wound Infections

Antibiotics
Background/Objectives: The optimal therapy for polymicrobial wound infections is poorly defined. We sought to characterize the ability of linezolid to combat mixed cultures of Staphylococcus aureus and Pseudomonas aeruginosa.
Samar A. Ahmed, Vy T. Luu, Teresa C. Oyono Nsuga, Steven E. Burgos, Eugene Kreys, Jered Arquiette, Justin R. Lenhard   +6 more
doaj   +1 more source

Development and characterisation of clindamycin hydrochloride loaded PLA/PLGA nanoparticles [PDF]

, 2012
Clindamycin hydrochloride drug most commonly used as antibiotics in dental and oral infection acts upon various bacterial infections also. In this experiment PLA and PLGA nanoparticle prepared and conjugated with Clindamycin hydrochloride drug.
Das, Niladri mohan
core  

OX40/OX40L modulation: A target for regulating T cells in cutaneous inflammatory disorders

Journal of the European Academy of Dermatology and Venereology, EarlyView.
OX40 and OX40L are a co‐stimulatory immune checkpoint pair. Modulation of this pair impacts multiple immune phenotypes and is an attractive target for immunotherapy in dermatological disorders. Trials are underway with the majority in atopic dermatitis and currently in phase 3 trials.
Aditya K. Gupta, Julia Steriopoulos, Vasiliki Economopoulos, Paradi Mirmirani, Vincent Piguet   +4 more
wiley   +1 more source